Published in Pain and Central Nervous System Week, November 7th, 2005
"Selegiline, a monoamine oxidase-B inhibitor, is reported to improve memory and learning in dementia of Alzheimer type," pharmacologists in Japan explained. "However, only a few studies have reported its use in animal models."
In their study, K. Takahata and coauthors at the Fujimoto Pharmaceutical Corporation in Osaka "evaluated the effects of selegiline only or its combined use with donepezil, a selective acetylcholinesterase inhibitor on memory impairment, using a Morris water maze."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain and Central Nervous System Week